Ryan L. Fleming
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 19
- Oncology 17
- HER2/EGFR in Cancer Research 14
- Co-authors
- Changshou Gao (19 shared papers)Nazzareno Dimasi (18 shared papers)Herren Wu (18 shared papers)Binyam Z. Bezabeh (11 shared papers)Steven R. Coats (3 shared papers)Leslie K. Wetzel (3 shared papers)Shenlan Mao (5 shared papers)Dorin Toader (3 shared papers)
- Journals
- mAbs (4 papers)Molecular Cancer Therapeutics (3 papers)Cancer Research (2 papers)Chemical Physics Letters (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Ryan L. Fleming
45 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 96
- Radiology, Nuclear Medicine and Imaging 911
- Oncology 851
- Molecular Medicine 87
- Molecular Biology 702
- Immunology 204
Countries citing papers authored by Ryan L. Fleming
This map shows the geographic impact of Ryan L. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan L. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan L. Fleming more than expected).
Fields of papers citing papers by Ryan L. Fleming
This network shows the impact of papers produced by Ryan L. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan L. Fleming. The network helps show where Ryan L. Fleming may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan L. Fleming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 348 | |
| 2 | 2014 | 239 | |
| 3 | 2008 | 133 | |
| 4 | 2017 | 120 | |
| 5 | 2015 | 115 | |
| 6 | 2009 | 83 | |
| 7 | 2017 | 66 | |
| 8 | 2016 | 58 | |
| 9 | 2018 | 54 | |
| 10 | 2016 | 52 | |
| 11 | 2016 | 47 | |
| 12 | 2014 | 42 | |
| 13 | 2017 | 40 | |
| 14 | 2018 | 39 | |
| 15 | 2016 | 36 | |
| 16 | 2021 | 30 | |
| 17 | 2019 | 29 | |
| 18 | 2015 | 28 | |
| 19 | 2018 | 21 | |
| 20 | 2017 | 20 |
About Ryan L. Fleming
Ryan L. Fleming is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Atomic and Molecular Physics, and Optics, Immunology and Molecular Biology, having authored 46 papers that have together received 1.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (19 papers), HER2/EGFR in Cancer Research (14 papers), Particle accelerators and beam dynamics (6 papers), Glycosylation and Glycoproteins Research (6 papers), Diamond and Carbon-based Materials Research (5 papers), Gyrotron and Vacuum Electronics Research (5 papers), Particle Accelerators and Free-Electron Lasers (4 papers) and Protein purification and stability (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (911 citations), Oncology (851 citations), Molecular Medicine (87 citations), Molecular Biology (702 citations) and Immunology (204 citations). Ryan L. Fleming has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Changshou Gao, Nazzareno Dimasi, Herren Wu, Binyam Z. Bezabeh, Steven R. Coats, Leslie K. Wetzel, Shenlan Mao, Dorin Toader, R. James Christie and Rakesh Dixit. Their work appears in journals such as mAbs, Molecular Cancer Therapeutics, Cancer Research, Chemical Physics Letters and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.